Applications and Outcomes of Central Extracorporeal Membrane Oxygenation: A Single Center Retrospective Review
Presented During: Welcome Reception and Poster Competition | Sponsored by: TransMedics
Pusan National University Hospital
Atlanta, GA
South Korea - Contact Me
Dr. Seunghwan Song is a dedicated cardiovascular surgeon with over two decades of experience in heart transplantation, left ventricular assist devices (LVAD), and extracorporeal membrane oxygenation (ECMO). Throughout his career, Dr. Song has made valuable contributions to clinical practice, research, and education in cardiovascular surgery. He is currently the Director of the Extracorporeal Life Support (ECLS) program and Surgical Director of the Heart Transplantation and Mechanical Circulatory Support (MCS) program at Pusan National University Hospital. Additionally, he serves as a Professor in the Department of Thoracic and Cardiovascular Surgery at Pusan National University School of Medicine, Busan, South Korea.
Friday, September 20, 2024: 5:00 PM - 6:30 PM
Omni King Edward Hotel
Description
Objective: In South Korea, the use of central extracorporeal membrane oxygenation (ECMO) is significantly less prevalent than peripheral ECMO, with substantial gaps in the literature regarding the primary indications and outcomes for central ECMO. The objective of this study was to analyze the outcomes of patients at our center who underwent treatment with central ECMO.
Methods: Data were retrospectively collected and analyzed for patients who underwent central ECMO our center from 2017 to 2024. The collected data included baseline characteristics of the patients, intraoperative details, and outcomes.
Results: Of the 11 patients who received central ECMO, 7 (63.6%) were transitioned from peripheral to central ECMO, within 7.8 days on average. ECMO support was initiated for post-cardiotomy shock in six patients and for non-postcardiotomy shock in five. Most applications of central ECMO were primarily intended as a bridge to long-term support, which was more common than bridging to transplantation (7 (63.6%) versus 4 (36.4%)). Weaning from central ECMO was successful in five patients (45.5%), including two who were transitioned to transplantation, two to long-term support, and one weaned without additional mechanical circulatory support. The in-hospital mortality rae among these patients was 54.5%
Conclusions: The majority of patients received central ECMO as a bridge to long-term support. Among the survivors, individuals who underwent transplantation or left ventricular assist device implantation predominated over those weaned from ECMO without additional mechanical circulatory support. To enhance our understanding of the outcomes associated with central ECMO and to identify the determinants of these outcomes, additional multicenter studies are warranted.
Authors
Seunghwan Song (1), Ho Seong Cho (2), Soojin Lee (3)
Institutions
(1) Pusan National University Hospital, Busan, NA, Korea, Republic of, (2) Pusan National University Hospital, Seo-Gu, Busan, (3) Pusan National University Hospital, Busan, NA
Methods: Data were retrospectively collected and analyzed for patients who underwent central ECMO our center from 2017 to 2024. The collected data included baseline characteristics of the patients, intraoperative details, and outcomes.
Results: Of the 11 patients who received central ECMO, 7 (63.6%) were transitioned from peripheral to central ECMO, within 7.8 days on average. ECMO support was initiated for post-cardiotomy shock in six patients and for non-postcardiotomy shock in five. Most applications of central ECMO were primarily intended as a bridge to long-term support, which was more common than bridging to transplantation (7 (63.6%) versus 4 (36.4%)). Weaning from central ECMO was successful in five patients (45.5%), including two who were transitioned to transplantation, two to long-term support, and one weaned without additional mechanical circulatory support. The in-hospital mortality rae among these patients was 54.5%
Conclusions: The majority of patients received central ECMO as a bridge to long-term support. Among the survivors, individuals who underwent transplantation or left ventricular assist device implantation predominated over those weaned from ECMO without additional mechanical circulatory support. To enhance our understanding of the outcomes associated with central ECMO and to identify the determinants of these outcomes, additional multicenter studies are warranted.
Authors
Seunghwan Song (1), Ho Seong Cho (2), Soojin Lee (3)
Institutions
(1) Pusan National University Hospital, Busan, NA, Korea, Republic of, (2) Pusan National University Hospital, Seo-Gu, Busan, (3) Pusan National University Hospital, Busan, NA